交易 AlloVir, Inc. - ALVR CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.05 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.026151% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003929% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Allovir Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Sep 22, 2023 | 2.26 | 0.07 | 3.20% | 2.19 | 2.28 | 2.16 |
Sep 21, 2023 | 2.25 | 0.12 | 5.63% | 2.13 | 2.32 | 2.10 |
Sep 20, 2023 | 2.25 | 0.09 | 4.17% | 2.16 | 2.38 | 2.13 |
Sep 19, 2023 | 2.21 | -0.01 | -0.45% | 2.22 | 2.22 | 1.89 |
Sep 18, 2023 | 2.12 | -0.38 | -15.20% | 2.50 | 2.51 | 2.08 |
Sep 15, 2023 | 2.48 | -0.18 | -6.77% | 2.66 | 2.69 | 2.41 |
Sep 14, 2023 | 2.68 | 0.22 | 8.94% | 2.46 | 2.73 | 2.44 |
Sep 13, 2023 | 2.44 | -0.21 | -7.92% | 2.65 | 2.66 | 2.44 |
Sep 12, 2023 | 2.64 | -0.15 | -5.38% | 2.79 | 2.84 | 2.63 |
Sep 11, 2023 | 2.83 | -0.05 | -1.74% | 2.88 | 2.91 | 2.76 |
Sep 8, 2023 | 2.87 | 0.01 | 0.35% | 2.86 | 2.89 | 2.72 |
Sep 7, 2023 | 2.85 | -0.14 | -4.68% | 2.99 | 3.00 | 2.83 |
Sep 6, 2023 | 3.01 | -0.04 | -1.31% | 3.05 | 3.12 | 2.80 |
Sep 5, 2023 | 3.03 | -0.14 | -4.42% | 3.17 | 3.30 | 3.01 |
Sep 1, 2023 | 3.19 | 0.02 | 0.63% | 3.17 | 3.29 | 3.15 |
Aug 31, 2023 | 3.12 | -0.14 | -4.29% | 3.26 | 3.33 | 3.10 |
Aug 30, 2023 | 3.28 | 0.10 | 3.14% | 3.18 | 3.42 | 3.18 |
Aug 29, 2023 | 3.24 | 0.10 | 3.18% | 3.14 | 3.43 | 3.14 |
Aug 28, 2023 | 3.19 | 0.18 | 5.98% | 3.01 | 3.21 | 3.01 |
Aug 25, 2023 | 2.97 | -0.05 | -1.66% | 3.02 | 3.10 | 2.92 |
AlloVir, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Wednesday, November 1, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家 US
| 事件 Q3 2023 Allovir Inc Earnings Release Q3 2023 Allovir Inc Earnings ReleaseForecast(预报) -上一页 - |
Tuesday, February 13, 2024 | ||
时间(协调世界时) (UTC) 13:30 | 国家 US
| 事件 Q4 2023 Allovir Inc Earnings Release Q4 2023 Allovir Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0.165 | 1.135 |
收入 | 0 | 0 | 0.165 | 1.135 | |
总营业费用 | 171.202 | 169.818 | 71.309 | 26.866 | 4.731 |
销售/一般/行政费用,总计 | 52.332 | 49.083 | 21.646 | 10.618 | 3.031 |
研究与开发 | 118.87 | 120.735 | 49.663 | 16.248 | 1.7 |
营业收入 | -171.202 | -169.818 | -71.309 | -26.701 | -3.596 |
利息收入(费用),非经营净值 | 1.876 | 1.315 | 1.33 | 2.065 | 0.056 |
其他,净值 | 0.351 | -2.452 | 0.195 | 0.797 | 1.11 |
税前净收入 | -168.975 | -170.955 | -69.784 | -23.839 | -2.43 |
税后净收入 | -168.71 | -171.962 | -69.784 | -23.839 | -2.43 |
未计算非常项目前的净收益 | -168.71 | -171.962 | -69.784 | -23.839 | -2.43 |
净收入 | -168.71 | -171.962 | -69.784 | -23.839 | -2.43 |
Total Adjustments to Net Income | -5.726 | ||||
普通股股东可获收益 (不含非经常性项目) | -168.71 | -171.962 | -69.784 | -23.839 | -8.156 |
普通股股东可获收益 (含非經常性項目) | -168.71 | -171.962 | -69.784 | -23.839 | -8.156 |
摊薄净收入 | -168.71 | -171.962 | -69.784 | -23.839 | -8.156 |
摊薄后加权平均股 | 76.6549 | 62.7821 | 61.9313 | 69.1735 | 69.1735 |
扣除特别项目的每股摊薄盈利 | -2.2009 | -2.73903 | -1.1268 | -0.34463 | -0.11791 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常摊薄盈利 | -2.2009 | -2.73903 | -1.1268 | -0.34463 | -0.11791 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 47.304 | 43.231 | 40.434 | 42.95 | 44.624 |
销售/一般/行政费用,总计 | 12.48 | 12.513 | 12.014 | 12.946 | 13.245 |
研究与开发 | 34.824 | 30.718 | 28.42 | 30.004 | 31.379 |
营业收入 | -47.304 | -43.231 | -40.434 | -42.95 | -44.624 |
利息收入(费用),非经营净值 | 1.516 | 1.325 | 0.898 | 0.668 | 0.162 |
其他,净值 | 0.521 | 0.723 | 0.985 | 0.21 | -0.027 |
税前净收入 | -45.267 | -41.183 | -38.551 | -42.072 | -44.489 |
税后净收入 | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
未计算非常项目前的净收益 | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
净收入 | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
普通股股东可获收益 (不含非经常性项目) | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
普通股股东可获收益 (含非經常性項目) | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
摊薄净收入 | -45.267 | -41.183 | -38.136 | -42.072 | -44.639 |
摊薄后加权平均股 | 94.6258 | 93.3037 | 92.9798 | 84.9488 | 64.4675 |
扣除特别项目的每股摊薄盈利 | -0.47838 | -0.44139 | -0.41015 | -0.49526 | -0.69243 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.47838 | -0.44139 | -0.41015 | -0.49526 | -0.69243 |
收入 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 243.052 | 253.348 | 361.317 | 127.313 | 25.313 |
现金和短期投资 | 233.795 | 248.12 | 356.324 | 126.077 | 22.199 |
现金等价物 | 106.092 | 201.661 | 122.661 | 61.084 | 22.199 |
短期投资 | 127.703 | 46.459 | 233.663 | 64.993 | 0 |
应收账款总额,净额 | 0.157 | 0.05 | 0.45 | 0.56 | 0.302 |
應收賬款 - 貿易,淨額 | 0 | 0.298 | 0.302 | ||
預付的費用 | 9.1 | 5.178 | 4.543 | 0.676 | 0.051 |
其他流動資産,總計 | 0 | 2.761 | |||
總資産 | 277.079 | 286.594 | 370.821 | 139.422 | 25.319 |
物業/廠房/設備,總計 - 淨額 | 32.563 | 31.292 | 9.504 | 12.109 | 0 |
其他長期資産,總計 | 1.464 | 1.954 | 0 | 0.006 | |
流動負債總額 | 24.338 | 37.853 | 12.294 | 9.106 | 3.737 |
應付賬款 | 3.004 | 8.361 | 0.963 | 0.63 | 0.153 |
預提費用 | 21.15 | 26.743 | 10.759 | 8.23 | 0.674 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.184 | 2.749 | 0.572 | 0.246 | 2.91 |
負債總額 | 52.56 | 61.328 | 17.757 | 17.798 | 3.737 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 28.222 | 23.475 | 5.463 | 8.692 | 0 |
總權益 | 224.519 | 225.266 | 353.064 | 121.624 | 21.582 |
Redeemable Preferred Stock | 0 | 0 | 0 | 173.127 | 52.204 |
普通股 | 0.009 | 0.007 | 0.007 | 0 | 0 |
額外實收資本 | 690.753 | 522.479 | 478.272 | 3.748 | 0.858 |
留存收益(累計赤字) | -465.775 | -297.065 | -125.103 | -55.319 | -31.48 |
Unrealized Gain (Loss) | 0.068 | 0 | |||
總負債和股東權益 | 277.079 | 286.594 | 370.821 | 139.422 | 25.319 |
已發行普通股總數 | 93.0932 | 63.5659 | 61.9313 | 69.1735 | 69.1735 |
物業/廠房/設備,總計 - 總額 | 33.567 | 31.573 | 9.596 | 12.128 | |
累計折舊,總計 | -1.004 | -0.281 | -0.092 | -0.019 | |
其他權益,總計 | -0.468 | -0.155 | -0.112 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 212.275 | 243.052 | 272.042 | 176.517 | 206.441 |
现金和短期投资 | 202.57 | 233.795 | 264.107 | 172.673 | 201.375 |
现金等价物 | 115.698 | 106.092 | 123.834 | 71.093 | 100.206 |
短期投资 | 86.872 | 127.703 | 140.273 | 101.58 | 101.169 |
应收账款总额,净额 | 0.244 | 0.157 | 0.261 | 0.091 | 0.172 |
預付的費用 | 9.461 | 9.1 | 7.674 | 3.753 | 4.894 |
總資産 | 244.044 | 277.079 | 293.698 | 199.995 | 231.09 |
物業/廠房/設備,總計 - 淨額 | 30.427 | 32.563 | 20.07 | 21.769 | 22.818 |
流動負債總額 | 24.959 | 24.338 | 20.719 | 21.588 | 18.639 |
應付賬款 | 4.134 | 3.004 | 4.889 | 5.518 | 4.473 |
預提費用 | 20.559 | 21.15 | 15.595 | 15.353 | 12.439 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.266 | 0.184 | 0.235 | 0.717 | 1.727 |
負債總額 | 50.512 | 52.56 | 40.472 | 41.858 | 39.415 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 25.553 | 28.222 | 19.753 | 20.27 | 20.776 |
總權益 | 193.532 | 224.519 | 253.226 | 158.137 | 191.675 |
普通股 | 0.009 | 0.009 | 0.009 | 0.007 | 0.007 |
額外實收資本 | 700.782 | 690.753 | 681.419 | 544.141 | 532.946 |
留存收益(累計赤字) | -506.958 | -465.775 | -427.639 | -385.567 | -340.928 |
Unrealized Gain (Loss) | |||||
總負債和股東權益 | 244.044 | 277.079 | 293.698 | 199.995 | 231.09 |
已發行普通股總數 | 93.428 | 93.0932 | 92.6401 | 64.7881 | 64.2641 |
其他長期資産,總計 | 1.342 | 1.464 | 1.586 | 1.709 | 1.831 |
其他權益,總計 | -0.301 | -0.468 | -0.563 | -0.444 | -0.35 |
Redeemable Preferred Stock | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -168.71 | -171.962 | -69.784 | -23.839 | -2.43 |
经营活动产生的现金 | -142.052 | -106.319 | -60.811 | -20.155 | 1.943 |
经营活动产生的现金 | 0.723 | 0.189 | 0.073 | 0.019 | 0 |
非现金物品 | 42.081 | 46.1 | 9.931 | 2.27 | 0.967 |
已付现金利息 | 0 | 0.125 | 0 | ||
营运资金的变化 | -16.146 | 19.354 | -1.031 | 1.395 | 3.406 |
投资活动产生的现金 | -80.478 | 185.983 | -169.497 | -64.644 | 0 |
资本支出 | 0 | -0.026 | -0.235 | -0.339 | 0 |
其他投资现金流量项目,总计 | -80.478 | 186.009 | -169.262 | -64.305 | 0 |
融资活动产生的现金 | 126.961 | 0.232 | 291.975 | 120.923 | 22.872 |
股票的发行(报废),净额 | 126.961 | 0.232 | 295.449 | 120.923 | 22.872 |
现金净变化 | -95.569 | 79.852 | 61.577 | 36.124 | 24.815 |
融资现金流项目 | 0 | -3.474 | |||
外汇效应 | 0 | -0.044 | -0.09 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -41.183 | -168.71 | -130.574 | -88.502 | -43.863 |
Cash From Operating Activities | -32.118 | -142.052 | -110.481 | -75.354 | -46.476 |
Cash From Operating Activities | 0.086 | 0.723 | 0.637 | 0.552 | 0.466 |
Non-Cash Items | 9.761 | 42.081 | 32.901 | 22.187 | 10.923 |
Changes in Working Capital | -0.782 | -16.146 | -13.445 | -9.591 | -14.002 |
Cash From Investing Activities | 41.724 | -80.478 | -94.015 | -55.458 | -54.979 |
Capital Expenditures | 0 | 0 | 0 | 0 | |
Other Investing Cash Flow Items, Total | 41.724 | -80.478 | -94.015 | -55.458 | -54.979 |
Foreign Exchange Effects | 0 | 0 | 0 | 0 | |
Net Change in Cash | 9.606 | -95.569 | -77.827 | -130.568 | -101.455 |
Cash From Financing Activities | 126.961 | 126.669 | 0.244 | 0 | |
Financing Cash Flow Items | 0 | ||||
Issuance (Retirement) of Stock, Net | 126.961 | 126.669 | 0.244 | ||
Cash Taxes Paid | 0 |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AlloVir, Inc. Company profile
关于 AlloVir Inc.
AlloVir, Inc.是一家处于后期临床阶段的细胞治疗公司。 公司从事开发同种异体T细胞疗法,以治疗和预防病毒性疾病。 其病毒特异性T细胞(VST)治疗平台能够产生VSTs,旨在恢复T细胞缺陷患者的免疫力。 其候选产品包括Viralym-M(ALVR105)、ALVR106、ALVR109、ALVR107和ALVR108。 其主要候选产品Viralym-M是一种多VST疗法,针对五种病毒。 BK病毒(BKV)、巨细胞病毒(CMV)、腺病毒(AdV)、爱泼斯坦-巴尔病毒(EBV)和人类疱疹病毒6(HHV-6)。 ALVR106是一种异体VST疗法,针对四种呼吸道病毒引起的疾病而开发:呼吸道合胞病毒(RSV)、流感、副流感病毒(PIV)和人偏肺病毒(hMPV)。 其LVR109是一种异体VST疗法,针对严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)。
Industry: | Bio Therapeutic Drugs |
1100 Winter Street
WALTHAM
MASSACHUSETTS 02451
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球555,000万多名交易者的一份子,选择利用Capital.com进行交易吧。